Rajeev Rajendra

Targeted treatment for advanced soft tissue sarcoma: profile of pazopanib

Robin L. Jones, S. Pollack, Rajeev Rajendra, 2013, OncoTargets and therapy.

Management of gastrointestinal stromal tumors.

Robin L. Jones, S. Pollack, Rajeev Rajendra, 2013, Future oncology.

Differential effects of the breast cancer resistance protein on the cellular accumulation and cytotoxicity of 9-aminocamptothecin and 9-nitrocamptothecin.

S. Bates, J. Schellens, D. Ross, 2003, Cancer research.

The topoisomerase I- and p53-binding protein topors is differentially expressed in normal and malignant human tissues and may function as a tumor suppressor

Maohui Luo, Honghua Li, E. Rubin, 2004, Oncogene.

Topors Functions as an E3 Ubiquitin Ligase with Specific E2 Enzymes and Ubiquitinates p53*

J. Brownell, S. Lutzker, E. Rubin, 2004, Journal of Biological Chemistry.

Phase I evaluation of sequential topoisomerase targeting with irinotecan/cisplatin followed by etoposide in patients with advanced malignancy.

D. Toppmeyer, L. Schaaf, E. Rubin, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Development of a bioanalytical liquid chromatography method for quantitation of 9-nitrocamptothecin in human plasma.

W. Shih, E. Rubin, M. Gounder, 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.